<![CDATA[Nanobiotix 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=19814>Fri, 15 May 2026 00:23:39 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Nanobiotix Announces the Selection of its Second NanoXray Product, NBTX-IV and a Collaboration with the National Cancer Institute for Development]]>https://www.newswire.co.kr/newsRead.php?no=702160Wed, 26 Jun 2013 15:13:32 +0900<![CDATA[Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with Lead Product NBTXR3]]>https://www.newswire.co.kr/newsRead.php?no=700306Thu, 13 Jun 2013 15:10:00 +0900<![CDATA[Nanobiotix's NBTXR3 Achieves Clinical Milestone Reaching Proof-Of-Concept in Phase I Trial of Soft Tissue Sarcoma]]>https://www.newswire.co.kr/newsRead.php?no=698877Tue, 04 Jun 2013 15:10:17 +0900